Patents by Inventor Stefan Galuska

Stefan Galuska has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10053737
    Abstract: The invention is directed to methods, reagents, and kits for the detection of MAPK/ERK pathway mutations in a patient diagnosed for cancer. In one embodiment, the invention comprises a sensitive and selective method to identify mutations to the BRAF, KRAS, and NRAS genes in a single reaction. In another aspect of this embodiment, the invention comprises primers and probes for the detection of the BRAF, KRAS, and NRAS mutations using a single nucleotide primer extension assay. In another embodiment the invention is used to identify and select patients amenable for treatment with an ERK inhibitor.
    Type: Grant
    Filed: April 3, 2014
    Date of Patent: August 21, 2018
    Assignee: MERCK SHARP & DOHME CORP.
    Inventors: Ken C. N. Chang, Stefan Galuska, Matthew J. Marton
  • Patent number: 4724145
    Abstract: High levels of immunity are achieved in chickens inoculated intramuscularly or orally with E. acervulina extract immunogens. These extracts contain at least 20 polypeptides which induce a protective immune response not only against E. acervulina but also against E. tenella and E. maxima. The resulting immunity prevents intestinal lesions and reduces the number of viable oocysts in vaccinated and challenged birds. One or more of these polypeptides can be used as an immunogen to protect against coccidiosis.
    Type: Grant
    Filed: November 18, 1985
    Date of Patent: February 9, 1988
    Assignee: Merck & Co., Inc.
    Inventors: Peter K. Murray, Balbir S. Bhogal, Ethel B. Jacobson, Mark S. Crane, Dennis M. Schmatz, Stefan Galuska
  • Patent number: 4639372
    Abstract: Sporozoites of coccidia fail to develop in chickens which are immune and many are blocked from penetrating host cells. Although previous attempts to immunize chickens with non-viable coccidial antigens have been unsuccessful it has been discovered that extracts from sporozoites or sporulated oocysts of E. tennella induce high levels of protective immunity. These extracts contain at least 15 polypeptides many of which are associated with the surface of the sporozoite and induce good immune responses. Antibody to these polypeptides blocks sporozoite-host cell penetration in vitro and neutralizes sporozoites in vivo. One or more of these polypeptides may be used as an antigen to protect against coccidiosis.
    Type: Grant
    Filed: June 29, 1984
    Date of Patent: January 27, 1987
    Assignee: Merck & Co., Inc.
    Inventors: Peter K. Murray, Stefan Galuska